155 related articles for article (PubMed ID: 22294531)
21. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
22. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Kapetanakis EI; Medlam DA; Boyce SW; Haile E; Hill PC; Dullum MK; Bafi AS; Petro KR; Corso PJ
Eur Heart J; 2005 Mar; 26(6):576-83. PubMed ID: 15723815
[TBL] [Abstract][Full Text] [Related]
23. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery.
Chan V; Kulik A; Bourke ME; Ressler L; Mesana TG; Ruel M
J Card Surg; 2007; 22(6):493-7. PubMed ID: 18039209
[TBL] [Abstract][Full Text] [Related]
24. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
[TBL] [Abstract][Full Text] [Related]
25. Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study.
Mannacio V; Meier P; Antignano A; Di Tommaso L; De Amicis V; Vosa C
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1299-306. PubMed ID: 24503325
[TBL] [Abstract][Full Text] [Related]
26. Use of tailored loading-dose clopidogrel in patients undergoing selected percutaneous coronary intervention based on adenosine diphosphate-mediated platelet aggregation.
Meng K; Lü SZ; Zhu HG; Chen X; Ge CJ; Song XT
Chin Med J (Engl); 2010 Dec; 123(24):3578-82. PubMed ID: 22166634
[TBL] [Abstract][Full Text] [Related]
27. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
[TBL] [Abstract][Full Text] [Related]
28. Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery.
Saadeh C; Sfeir J
J Vasc Surg; 2013 Dec; 58(6):1586-92. PubMed ID: 23891491
[TBL] [Abstract][Full Text] [Related]
29. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin.
Ouattara A; Bouzguenda H; Le Manach Y; Léger P; Mercadier A; Leprince P; Bonnet N; Montalescot G; Riou B; Coriat P
Eur Heart J; 2007 Apr; 28(8):1025-32. PubMed ID: 17431000
[TBL] [Abstract][Full Text] [Related]
30. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery.
Kwak YL; Kim JC; Choi YS; Yoo KJ; Song Y; Shim JK
J Am Coll Cardiol; 2010 Dec; 56(24):1994-2002. PubMed ID: 21126640
[TBL] [Abstract][Full Text] [Related]
31. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
33. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.
Takiuchi H; Tanemoto K
Gen Thorac Cardiovasc Surg; 2015 Nov; 63(11):601-6. PubMed ID: 26298730
[TBL] [Abstract][Full Text] [Related]
34. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
35. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting.
Pickard AS; Becker RC; Schumock GT; Frye CB
Pharmacotherapy; 2008 Mar; 28(3):376-92. PubMed ID: 18294117
[TBL] [Abstract][Full Text] [Related]
36. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution.
Ascione R; Ghosh A; Rogers CA; Cohen A; Monk C; Angelini GD
Ann Thorac Surg; 2005 Apr; 79(4):1210-6. PubMed ID: 15797051
[TBL] [Abstract][Full Text] [Related]
37. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.
Price MJ; Coleman JL; Steinhubl SR; Wong GB; Cannon CP; Teirstein PS
Am J Cardiol; 2006 Sep; 98(5):681-4. PubMed ID: 16923461
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial.
Shi J; Ji H; Ren F; Wang G; Xu M; Xue Y; Chen M; Qi J; Li L
JAMA Surg; 2013 Jun; 148(6):538-47. PubMed ID: 23426385
[TBL] [Abstract][Full Text] [Related]
39. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome.
Song SW; Youn YN; Yi G; Lee S; Yoo KJ
Circ J; 2008 Apr; 72(4):626-32. PubMed ID: 18362436
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
Angiolillo DJ; Shoemaker SB; Desai B; Yuan H; Charlton RK; Bernardo E; Zenni MM; Guzman LA; Bass TA; Costa MA
Circulation; 2007 Feb; 115(6):708-16. PubMed ID: 17261652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
